What are the etiologies and treatment options for pruritus in a dialysis patient?

Pruritus in Dialysis Patients: Etiology and Treatment

Etiologies of Uremic Pruritus

Pruritus affects 66-74% of dialysis patients and stems from multiple interconnected mechanisms, with inadequate dialysis being the most modifiable factor. 1, 2

Primary Contributing Factors

• Inadequate dialysis dose is strongly associated with higher pruritus rates; achieving a Kt/V of approximately 1.6 significantly reduces itch prevalence 1, 2
• Xerosis (dry skin) occurs in 54-69% of hemodialysis patients and lowers the threshold for itch, making it the most common cutaneous finding 1, 3
• Secondary and tertiary hyperparathyroidism with calcium-phosphate imbalance contributes to pruritus development 1, 3
• Anemia may exacerbate symptoms and should be corrected with erythropoietin 1

Clinical Patterns

• Pruritus can be generalized (50% of cases) or localized to the back, face, or arteriovenous fistula arm 1
• Symptoms may worsen during summer, at night, or during/after dialysis sessions 1
• Severity ranges from mild intermittent irritation to intractable itch that severely disrupts sleep and quality of life 1, 4

Important Differential Diagnosis

• Drug-induced eruptions from dialysis-related medications should always be considered 3, 5
• In female patients with genital itching, lichen sclerosus (porcelain-white papules/plaques with nocturnal itch) must be ruled out 5

---

Treatment Algorithm

Step 1: Optimize Dialysis Parameters (Foundation)

Before initiating any pharmacologic therapy, optimize dialysis adequacy and metabolic parameters. 1

• Target Kt/V of 1.6 to reduce pruritus prevalence 1, 2
• Normalize calcium-phosphate balance and control parathyroid hormone levels 1
• Correct anemia with erythropoietin if present 1
• Apply emollients regularly to all patients to address xerosis 1, 3

Step 2: First-Line Pharmacologic Treatment

Gabapentin 100-300 mg administered intravenously after each dialysis session (three times weekly) is the most effective medication for uremic pruritus. 1

• Start with 100 mg post-dialysis, titrate to 200 mg if inadequate response, maximum 300 mg per session 1
• These doses are substantially lower than non-ESRD populations due to reduced renal clearance 1
• High-quality multicenter, double-blind, placebo-controlled trial showed >50% reduction in visual analogue itch scores 1
• Most common side effect is mild drowsiness 1

Step 3: Adjunctive Topical Therapy

Topical capsaicin 0.025% cream applied four times daily to affected areas provides marked relief in the majority of patients. 1

• 14 of 17 patients showed marked improvement, with 5 achieving complete remission in randomized trials 1
• Mechanism: depletes substance P in peripheral sensory neurons 1
• Antipruritic benefit persists up to 8 weeks after discontinuation 1
• Warn patients about initial burning/stinging that resolves with continued use 1
• For localized patches, topical calcipotriol can be used as an alternative 1

Step 4: Phototherapy for Refractory Cases

If symptoms persist after 2-4 weeks of optimized dialysis and pharmacologic treatment, escalate to broad-band UVB (BB-UVB) phototherapy. 1

• Strong evidence supports BB-UVB efficacy for uremic pruritus 1
• Effective for patients who cannot tolerate or do not respond to medications 1

Step 5: Advanced Therapy

Difelikefalin (kappa-opioid receptor agonist) is the only FDA-approved medication specifically for CKD-associated pruritus. 1

• Large-scale trials with >1,400 hemodialysis patients treated for up to 64 weeks showed significant and sustained itch relief 1
• Consider for severe, refractory cases 1

---

Critical Medications to AVOID

Ineffective Antihistamines

• Cetirizine 10 mg daily is NOT effective for uremic pruritus despite efficacy in other pruritic conditions 1, 5
• Long-term sedating antihistamines (diphenhydramine, hydroxyzine) should be avoided except in palliative settings due to dementia risk 1, 5
• Non-sedating antihistamines (fexofenadine 180 mg, loratadine 10 mg) have limited evidence for uremic pruritus 1

Ineffective Topical Agents

• Calamine lotion has no supporting literature for uremic pruritus 1, 5
• Crotamiton cream was shown ineffective compared to vehicle control 1, 5
• Menthol provides only counter-irritant effect without true antipruritic mechanism 1

Restricted Use Agents

• Topical doxepin must be strictly limited to ≤8 days, ≤10% body surface area, and ≤12 g daily to prevent systemic toxicity 1, 5

---

Common Pitfalls and How to Avoid Them

Dosing Errors

• Never use standard non-renal gabapentin dosing in dialysis patients; the 100-300 mg post-dialysis regimen prevents excess sedation and drug accumulation 1
• Fexofenadine 180 mg does not require dose adjustment in renal impairment and is the preferred non-sedating antihistamine when needed 5

Overlooked Factors

• Always assess dialysis adequacy first; pruritus is more common in underdialyzed patients 1, 2
• Do not assume all genital itching is uremic; examine for lichen sclerosus (requires high-potency topical corticosteroids) 5
• Consider drug-induced eruptions from dialysis medications in the differential 3, 5

Quality of Life Impact

• Severe pruritus is associated with increased mortality (HR 1.24), higher hospitalization rates, depression, sleep disruption, and dialysis withdrawal 1, 4
• Aggressive management is warranted given these far-reaching consequences 4

---

Definitive Treatment

Renal transplantation is the only definitive cure for uremic pruritus, though feasibility varies by patient. 1, 5

• Should be considered for eligible patients with refractory severe itch 1
• Observational data link transplantation to complete resolution of pruritus 1